Search results
Showing 3286 to 3300 of 7680 results
The different types of health, public health and social care information provided by NICE.
The appeal panel is drawn from a group of people approved by the Secretary of State for Health and Social Care to hear appeals. Read the appeal panel
How we collect and use your personal information, and your rights under data protection legislation
Diabetes: blood pressure (without moderate or severe frailty)
This indicator has been updated and replaced by NICE indicator 249.
Atrial fibrillation: pulse rhythm assessment in people at risk
This indicator has been withdrawn following National Screening Committee recommendations and ongoing research.
This indicator has been withdrawn following discussions with the National Screening Committee.
A new model for evaluating and purchasing antimicrobials in the UK
Antimicrobial resistance (AMR) is an urgent global challenge. It causes around 700,000 deaths each year globally . That number is predicted to rise to
Support for industry to engage with NICE during all stages of health technology development
NICE research projects and partners.
We estimate the costs or savings (budget impact) associated with technologies and guidelines so you can plan for and implement guidance.
Our tool to help you plan for and implement NICE guidance. View upcoming guidance and understand the impact of guidance on your resources.
Should I stop my benzodiazepine or z-drug? Patient decision aid: summary Do not stop taking your benzodiazepine or z-drug suddenly What are...
This indicator covers the proportion of children and young people with diabetes who have had their glycated haemoglobin A1c (HbA1c) monitored in the previous 12 months. It measures outcomes that reflect the quality of care or processes linked by evidence to improved outcomes. This indicator was previously published as CCG67
Health Technology Assessment Innovation Laboratory (HTA Lab)
NICE's HTA Lab enables us to develop creative solutions to complex problems in health technology assessment.
Our health inequalities guidance supports strategies that improve population health as a whole, while offering particular benefit to the most disadvantaged